March 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 05, 2025
Projections indicate that, the global anti-hypertensive drugs market will increase from USD 26.76 billion in 2025 to USD 39.2 billion by 2035, experiencing a CAGR of 3.89% over the next 10 years. Market growth is driven by the rising prevalence of hypertension, aging populations, and advancements in medications targeting blood pressure management. ...
November 04, 2025
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, the globe is increasingly demanding affordable drugs, including diverse biologics. North America regi...
November 03, 2025
The insulin API market report presents a complete segmentation and trade analysis covering human insulin, analog insulin, and biosimilar APIs. It provides regional data for NA, EU, APAC, LA, and MEA, highlighting production volumes, demand patterns, and cross-border trade flow. The market’s expansion, projected to reach USD 10.21 billion by 2...
November 03, 2025
The gestational diabetes market features comprehensive segmentation and statistical coverage, spanning treatment methods, drug formulations, dosage forms, diagnostics, and end-use industries. It includes global and regional market data, trade analysis, supply chain mapping, and competitive positioning of top companies. Each region’s performan...
November 03, 2025
The aesthetic injectables market is valued at USD 16.12 billion in 2025 and is projected to reach USD 38.8 billion by 2034 at a CAGR of 10.26%. Covering NA, EU, APAC, LA, and MEA, the report includes segmentation by product type, treatment, and end user, along with profiles of AbbVie/Allergan, Galderma, Merz, and Ipsen, plus trade, supply chain, an...
November 01, 2025
The small molecules market is growing as it is used in drug discovery, cancer therapies, neurological disorders, and cellular therapeutics, as it has a variety of biological functions. North America is dominant in the market due to increasing significant investment in R&D and a robust government framework....
November 01, 2025
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patient-specific therapies, is estimated to drive the growth of the market. North America led the global ...
November 01, 2025
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral vector CDMO including therapeutic development and clinical trials drive the expansion of these organ...
November 01, 2025
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing demand for personalized medicines bolster market growth. The availability of state-of-the-art resear...
November 01, 2025
According to market projections, the serum gonadotrophin API sector is expected to grow from USD 131 million in 2024 to USD 202.93 million by 2034, reflecting a CAGR of 4.64%. The market is growing due to rising demand for fertility treatment and assisted reproductive technologies. Additionally, the increasing prevalence of infertility and the expa...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com